Mosaic raises $47M for AI-guided surgical catheter
Mosaic Intelligence Labs emerged from stealth with $47 million raised across two seed rounds led by 8VC and Fundomo, with Lingotto Innovation and Obvious Ventures also investing. The San Francisco startup is initially targeting endovascular procedures with a semi-autonomous catheter whose tip bends to navigate veins and arteries as a surgeon advances it. Mosaic also describes a sensor-driven platform intended to provide updated anatomical views and robotic control.
The reported seed financing and endovascular focus make Mosaic a notable early-stage AI medical-device effort, although its catheter-navigation capabilities remain company claims.

Mosaic Intelligence Labs, a San Francisco startup building AI-guided surgical instruments, has come out of stealth with $47m. It raised the money in two seed rounds led by 8VC and Fundomo, the one-year-old company told The Information. Lingotto Innovation and Obvious Ventures also invested, Mosaic said on Tuesday.
The company is starting with endovascular procedures. In these, doctors guide thin wires and catheters through blood vessels to treat organs. Its semi-autonomous catheter can “find its own way” through a patient’s blood vessels, co-founder and chief executive Ileana Pirozzi told The Information. As the surgeon feeds it in, its tip bends to follow the right veins and arteries.
#Mosaic Intelligence Labs#Mosaic semi-autonomous catheter#8VC#Fundomo#Lingotto Innovation#Obvious Ventures